<Record><identifier xmlns="http://purl.org/dc/elements/1.1/">URN:NBN:SI:doc-FLQWOSOE</identifier><date>2013</date><creator>Hajdinjak, Tine</creator><creator>Kmetec, Andrej</creator><relation>documents/doc/F/URN_NBN_SI_doc-FLQWOSOE_001.pdf</relation><relation>documents/doc/F/URN_NBN_SI_doc-FLQWOSOE_001.txt</relation><format format_type="issue">3</format><format format_type="volume">47</format><format format_type="type">article</format><format format_type="extent">str. 289-295, VI</format><identifier identifier_type="ISSN">1318-2099</identifier><identifier identifier_type="COBISSID">269154048</identifier><identifier identifier_type="URN">URN:NBN:SI:doc-FLQWOSOE</identifier><language>eng</language><publisher>Association of Radiology and Oncology</publisher><source>Radiology and oncology (Ljubljana)</source><rights>BY</rights><subject language_type_id="slv">analgetiki</subject><subject language_type_id="slv">bolečina</subject><subject language_type_id="slv">bolniki</subject><subject language_type_id="slv">rak (medicina)</subject><subject language_type_id="slv">zasevki</subject><title>Evaluation of safety and analgesic consumption in patients with advanced cancer treated with zoledronic acid</title></Record>